Generics and Biosimilars Initiative Journal · 2018 · 13 citations · 0 references
LawBiotechnologyIntellectual Property LawIntellectual PropertyPatent LawScience PolicyBiosimilar RegulationInnovation PolicyIntellectual Property ProtectionIntellectual Property RightsMarket Authorization ProceduresRegulatory StrategyAccess To BiosimilarsMarket Access For BiosimilarsRegulatory Frameworks For Biosimilars
Author byline as per print journal: Steven Simoens, PhD; Claude Le Pen, PhD; Niels Boone, PharmD; Ferdinand Breedveld, MD, PhD; Antonella Celano; Antonio Llombart-Cussac, MD, PhD; Frank Jorgensen, MPharm, MM; Andras Süle, PhD; Ad A van Bodegraven, MD, PhD; Rene Westhovens, MD, PhD; Jo De Cock Introduction/Objectives: